Prof. Dr. Syed Nisar Hussain Shah - Pharmaceutics Specialist

Medically reviewed by Prof. Dr. Syed Nisar Hussain Shah, Ph.D (Pharmaceutics), Post-doc (Ghent University)

Written by Dr. Muhammad Imran, M.Phil, PharmD, BSc

Updated on

Migraine Burden - FINAL Removed Small Boxes
LIVE ESTIMATE • GLOBAL PREVALENCE
1,100,000,000+ AFFECTED GLOBALLY
PREVALENCE1 in 7of world population
Live counter +1 / 2s
W

WHO: Migraine is among top causes of disability worldwide. Approximately 1 in 7 people live with migraine — second leading cause of years lived with disability.

LIVE ATTACK ONSET

EST. ATTACKS TODAY

18,473,020++2/s

Real-time extrapolation • 12M attacks/day global est.

Live • ~139 attacks per second • Peak mornings
◐
GBD 2019

DAILY ATTACKS WORLDWIDE

18,473,020+

Estimated new onsets today

Live • +2 per sec • peak mornings
⚠
#2 CAUSE

YEARS LIVED WITH DISABILITY

2nd leading YLD

WHO ranks migraine top disabling

15-49y most affected group
♀
3X HIGHER

WOMEN PREVALENCE

~18% women

vs ~6% men • Hormonal link

Peak 35-39 years
$
US $36B+

ANNUAL ECONOMIC BURDEN

Healthcare + lost productivity

USA direct + indirect costs

13B workdays lost annually

Estimates extrapolated from WHO GBD 2019 • 1.1B prevalence baseline • Live ticker for awareness, not clinical count • WHO ICD-11 8A80

Understanding Migraine

NIH Migraine Definition Card

Clinical Definition of Migraine

NIH Reference
According to the National Institutes of Health (NIH), a migraine is a disabling neurological disorder characterized by recurrent episodes of moderate-to-severe, typically unilateral, throbbing head pain. Beyond head pain, a migraine involves complex brainstem activation, trigeminovascular neuropeptide release, and central sensory processing changes.
A study by Charles et al., 2021 stated that 'cortical spreading depression acts as the primary neurophysiological generator for migraine aura, triggering subsequent trigeminovascular activation and central sensitization.'
Migraine & Brain Chemistry — Visual Guide

Migraine & Brain Chemistry

Migraines happen because certain brain chemicals go out of balance,
over-activating the brain's main pain pathway — the trigeminal nerve system.

The trigger cascade

Step 1
Trigger exposure
Stress, hormonal shifts, poor sleep, skipped meals, nitrate-containing foods/medicines
↓
Step 2
Brakes fail
Serotonin and GABA — the brain's calming chemicals — drop
↓
Step 3
Pain signal surge
Glutamate and CGRP fire excessively at nerve synapses
↓
Step 4
Nerve sensitization
Blood vessels widen; pain nerves become hypersensitive
↓
Step 5
Full migraine attack
Throbbing pain, light/sound sensitivity, nausea

The chemicals behind the attack

Serotonin

The failing brake

Normally keeps pain signals under control. Levels fall during an attack, letting pain fire more freely.

CGRP

The main trigger

Spikes during an attack, widening blood vessels and sensitizing pain nerves. Target of nearly all modern migraine drugs.

Glutamate

The excitatory overload

The brain's main "excite" chemical. Excess firing contributes to aura — the visual/sensory disturbances before an attack.

Dopamine & norepinephrine

Off-balance early signals

Dopamine rises while norepinephrine falls, linked to nausea, yawning, and mood changes before the headache starts.

GABA

The calm-down force

The brain's natural inhibitor. When it weakens, excess glutamate excitement goes unchecked.

Nitric oxide (NO)

The known trigger

Excites pain nerves directly — why nitrate-containing foods and medicines are common migraine triggers.

PACAP, substance P, VIP

Amplifiers

Additional pain-signaling molecules that add fuel to the same trigeminal pathway once an attack has started.

migraine pathophysiology

Migraine vs. Tension Headache

Migraine vs Tension Headache Comparison

Migraine vs. Tension-Type Headache

Clinical comparison based on ICHD-3 diagnostic parameters.

Clinical Feature
Migraine
Tension-Type Headache
Pain Location
Migraine Unilateral (60%) or bilateral; frontotemporal region.
Tension-Type Headache Bilateral; "band-like" distribution around forehead and occiput.
Pain Quality
Migraine Pulsating or throbbing.
Tension-Type Headache Pressing, tightening, or dull ache (non-throbbing).
Severity & Impact
Migraine Moderate to severe; worsens with routine physical activity.
Tension-Type Headache Mild to moderate; does not worsen with routine physical activity.
Associated Symptoms
Migraine Photophobia, phonophobia, nausea, vomiting, or visual aura.
Tension-Type Headache Absence of nausea/vomiting; mild photophobia or phonophobia (not both).
Pathophysiology
Migraine Trigeminovascular activation and neurogenic CGRP release.
Tension-Type Headache Pericranial myofascial tenderness and peripheral nociception.
A study by Arnold et al., 2021 stated that 'strictly applying ICHD-3 criteria differentiates migraine based on its unilateral throbbing quality, aggravation by routine physical activity, and associated sensory phobias.'
02 - 4 Stages - V3 Elementor Safe - No Font Link
02

The 4 Stages of a Migraine Attack Prodrome Aura Headache Postdrome

Interactive timeline • Prevalence annotated
Timeline Graphic • Live
How an attack unfolds — brain to pain
Clinical pearl: 80% prodrome • 25% aura • 100% headache (except silent) • 68% postdrome. Ask about yawning, cravings, neck stiffness — often missed prodrome clues.
MIGRAINE COMPARISON WITH AURA vs WITHOUT AURA ⚠️ MIGRAINE WITH AURA (Classic Migraine) Aura Symptoms (20–60 min before): 👁️ Visual disturbances • Flashing lights / zigzag lines • Blind spots / vision loss 🤚 Numbness / tingling 🗣️ Speech difficulty 💪 Muscle weakness ⏱️ Timing & Prevalence: • Aura: 20–60 min | Total: 4–72 hrs • Affects ~25–30% of migraine sufferers ★ Key Feature: Neurological warning BEFORE headache 🚫 MIGRAINE WITHOUT AURA (Common Migraine) Symptoms (No warning phase): 🤕 Moderate to severe head pain 💓 Throbbing / pulsating quality ↔️ Usually unilateral (one side) 🤢 Nausea / vomiting 💡 Sensitivity to light & sound ⏱️ Timing & Prevalence: • Direct onset | Total: 4–72 hrs • Affects ~70–75% of migraine sufferers ★ Key Feature: NO neurological warning before headache SHARED CLINICAL FEATURES • Unilateral or bilateral headache • Associated nausea / vomiting • Photophobia & phonophobia • Significant routine functional disability Common Shared Triggers: • Stress, hormonal fluctuations, sleep disruption • Dietary triggers, weather & environmental changes
🧠 MIGRAINE TRIGGERS: FULL LIST 🍕 FOOD & DRINKS • Aged cheese (tyramine) • Processed meats (nitrates) • Red wine / alcohol • Chocolate • Caffeine (excess or withdrawal) • MSG / artificial sweeteners • Citrus fruits / bananas 🌦️ WEATHER & ENVIRONMENT • Barometric pressure changes • High humidity • Extreme heat or cold • Bright sunlight / glare • Strong winds • High altitude • Loud noises / strong smells 🔄 HORMONAL CHANGES • Menstruation (estrogen drop) • Ovulation • Pregnancy • Perimenopause / menopause • Hormonal contraceptives • HRT (hormone replacement) 😰 STRESS & EMOTIONAL • Emotional stress / anxiety • Post-stress "let-down" • Depression • Excitement / shock • Overwork / burnout • Major life changes 😴 SLEEP PATTERNS • Too little sleep • Too much sleep • Irregular sleep schedule • Jet lag / shift work • Sleep apnea / snoring • Weekend sleep catch-up 📱 SCREEN TIME & TECH • Prolonged screen use • Blue light exposure • Screen glare / flicker • Poor posture (neck strain) • Eye strain / digital fatigue • Loud headphones / earbuds
🧠 TYPES OF MIGRAINE Classification based on ICHD-3 — with and without aura, plus rare variants 🟠 MIGRAINE WITHOUT AURA (Common Migraine) — ~70–75% of cases Moderate–severe throbbing pain Usually one-sided Nausea, light & sound sensitivity No aura / no neurological warning 🔵 MIGRAINE WITH AURA (Classic Migraine) — ~25–30% of cases Visual disturbances (zigzags, flashes) Numbness / tingling Speech difficulty Aura lasts 20–60 min before headache 🔴 CHRONIC MIGRAINE ~2–4% of population ≥15 headache days/month For ≥3 months ≥8 migraine days/month High disability — daily interference 💪 HEMIPLEGIC MIGRAINE Rare — genetic (familial or sporadic) Motor weakness on one side Visual, sensory, speech symptoms Aura can last hours to days May mimic stroke — needs evaluation 👁️ RETINAL MIGRAINE Rare — ocular type Repeated monocular visual loss Blind spots / temporary blindness One eye only (not both) Headache follows visual loss 🌀 BRAINSTEM AURA MIGRAINE Formerly "Basilar-type" Vertigo / dizziness Double vision / tinnitus Slurred speech / ataxia No weakness — differentiates from hemiplegic ⏰ STATUS MIGRAINOSUS Medical emergency Debilitating attack lasting >72 hours Continuous pain despite treatment Severe nausea / vomiting Requires urgent medical care 🔄 VESTIBULAR MIGRAINE Common cause of vertigo Recurrent dizziness / vertigo Headache may be absent Motion sensitivity Often responds to migraine treatment 🩸 MENSTRUAL & HORMONAL MIGRAINE Affects up to 60% of women with migraine Attacks linked to menstrual cycle Estrogen withdrawal triggers headache Pure menstrual: days −2 to +3 of period Menstrually-related: also at other times 🫄 ABDOMINAL MIGRAINE Mostly children — rare in adults Recurrent abdominal pain Nausea / vomiting / anorexia No headache required for diagnosis Often evolves into migraine later 📌 KEY TAKEAWAY Migraine is not just a headache — it is a neurological disorder with distinct subtypes. Accurate classification guides treatment and helps identify serious complications.
🧠 CHRONIC MIGRAINE vs EPISODIC MIGRAINE Chronic Migraine: ≥15 headache days/month for 3+ months, with ≥8 migraine days/month CHRONIC MIGRAINE — DEFINITION ICHD-3 Criteria: Headache on ≥15 days/month For >3 months (≥12 weeks) With ≥8 migraine-like days/month EPISODIC MIGRAINE — DEFINITION ICHD-3 Criteria: Headache on <15 days/month At least 5 attacks total Attacks last 4–72 hours untreated 📅 TIMELINE COMPARISON (1 MONTH) CHRONIC ≥15 headache days Headache day Headache-free EPISODIC <15 headache days 📊 SIDE-BY-SIDE COMPARISON Feature 🔴 Chronic Migraine 🟢 Episodic Migraine Headache days/month ≥ 15 days < 15 days Duration ≥ 3 months (continuous) Episodic attacks Migraine days/month ≥ 8 days Varies (often 1–8) Prevalence ~2–4% of population ~14–15% of population Disability level High — daily interference Low–moderate — episodic ⚠️ RISK FACTORS FOR CHRONIFICATION (Episodic → Chronic) • Medication overuse • High attack frequency • Obesity • Depression / anxiety • Sleep disorders
🩺 HOW MIGRAINE IS DIAGNOSED Based on ICHD-3 criteria — diagnosis is clinical, relying on history and pattern recognition 1 📋 CLINICAL HISTORY The cornerstone of diagnosis Detailed headache diary review Frequency, duration, intensity Location, quality, associated symptoms Triggers, relief factors, family history 2 📖 ICHD-3 CRITERIA International Classification of Headache Disorders At least 5 attacks fulfilling criteria Attacks lasting 4–72 hours untreated At least 2 of: unilateral, pulsating, moderate/severe, aggravated by activity At least 1 of: nausea/vomiting, photophobia/phonophobia 3 🔍 PHYSICAL EXAMINATION To exclude secondary causes Neurological examination Blood pressure measurement Eye examination / fundoscopy Neck and temporomandibular joint exam 4 🧪 DIAGNOSTIC TESTS Not routinely needed — used to rule out other causes MRI / CT brain (if red flags present) Blood tests (rule out infection, anemia) Lumbar puncture (rarely indicated) EEG (only if seizure suspected) 📖 ICHD-3 DIAGNOSTIC CRITERIA FOR MIGRAINE WITHOUT AURA A At least 5 attacks fulfilling criteria B–D Recurrent moderate or severe headache attacks B Headache attacks lasting 4–72 hours (untreated or unsuccessfully treated) In children, attacks may last 2–72 hours C At least 2 of the following 4 characteristics: Unilateral • Pulsating • Moderate/severe • Aggravated by routine activity D At least 1 of the following: Nausea and/or vomiting • Photophobia and phonophobia 🚩 RED FLAGS — WHEN TO SUSPECT SECONDARY HEADACHE SNOOP4 mnemonic: S — Systemic symptoms Fever, weight loss, night sweats N — Neurological signs Confusion, weakness, altered consciousness O — Onset sudden (thunderclap) Maximal intensity within 1 minute O — Older age (>50 years) New onset headache in older adults P — Pattern change Progressive worsening, new triggers P — Positional Worse lying down or standing If any red flag is present → urgent imaging and specialist referral 📌 KEY TAKEAWAY Migraine is a clinical diagnosis — no blood test or imaging confirms it. A thorough history and ICHD-3 criteria are the gold standard for accurate diagnosis.
Migraine vs. Sinus Headache
🧠 MIGRAINE vs CLUSTER HEADACHE Two distinct primary headache disorders — different pain, patterns, and treatments 📍 TYPICAL PAIN LOCATION & CHARACTER 🧠 MIGRAINE Usually one-sided Frontal / temporal / retro-orbital Throbbing • Pulsating 🔴 CLUSTER HEADACHE tearing ptosis congestion Strictly one-sided Orbital / supraorbital / temporal Excruciating • Piercing / boring 📊 SIDE-BY-SIDE COMPARISON Feature 🧠 Migraine 🔴 Cluster Headache Sex ratio Female > Male (approximately 3:1) Male > Female (approximately 3–4:1) Age of onset Any age Often teens to 30s 20–40 years Rare in children Pain quality Throbbing / pulsating Moderate to severe Excruciating, piercing Boring / drilling sensation Attack duration 4–72 hours Untreated or unsuccessfully treated 15–180 minutes If untreated Frequency Episodic or chronic Varies widely 1–8 attacks per day In cluster periods Autonomic symptoms Mild Nasal congestion, runny nose Hallmark feature Tearing, ptosis, redness, miosis Behavior during attack Prefers lying down Quiet, dark room Pacing, restless Cannot sit still Triggers Stress, foods, hormones Sleep changes, sensory stimuli Alcohol, smoking Strong smells, daytime napping Treatment Triptans, NSAIDs, preventives CGRP inhibitors, beta-blockers High-flow oxygen, sumatriptan Verapamil for prevention Suicidal ideation Rare Common — pain is unbearable 📌 KEY CLINICAL PEARL Cluster headache is a neurological emergency — not just a severe headache. Patients pace and cannot lie still — this is a key differentiator from migraine. Oxygen and sumatriptan are first-line acute treatments — both are highly effective.
migraine vs cluster headche
💪 HEMIPLEGIC MIGRAINE: COMPLETE VISUAL GUIDE A rare, severe migraine subtype with motor weakness — requires specialist care 📖 DEFINITION What is Hemiplegic Migraine? Rare subtype of migraine with aura Characterized by motor weakness Weakness is reversible but can last hours to days Can be familial (genetic) or sporadic Often misdiagnosed as stroke 🧬 TYPES Two Main Forms: Familial Hemiplegic Migraine (FHM) • Runs in families (autosomal dominant) • Types 1, 2, 3 (CACNA1A, ATP1A2, SCN1A) Sporadic Hemiplegic Migraine (SHM) • No family history • Same symptoms, different genetic basis ⚠️ SYMPTOMS Motor Symptoms (Hallmark): Weakness on one side of body Hemiparesis / hemiplegia May affect face, arm, or leg Other Aura Symptoms: Visual disturbances Sensory changes (numbness, tingling) Speech difficulty (aphasia) Confusion / altered consciousness Fever / meningismus (in some cases) 🔄 PHASES OF AN ATTACK 1. Prodrome (hours to days before): Mood changes, food cravings, yawning 2. Aura (gradual onset): Motor weakness, visual changes, speech difficulty 3. Headache (may be absent): Throbbing pain, nausea, light/sound sensitivity 4. Postdrome (hours to days after): Fatigue, confusion, weakness may persist 💊 TREATMENT Acute Treatment: NSAIDs / acetaminophen Antiemetics (nausea) ⚠️ Triptans: use with caution (may be contraindicated in some) Preventive Treatment: Calcium channel blockers (verapamil) Anticonvulsants (topiramate, valproate) CGRP inhibitors (newer options) Avoid triggers + lifestyle modifications 🚨 WHEN TO SEEK EMERGENCY CARE Call emergency services if: Sudden, severe "thunderclap" headache Weakness lasting >24 hours Difficulty breathing or swallowing Loss of consciousness / confusion Fever with stiff neck First-ever attack with weakness Symptoms mimicking stroke ⚠️ Hemiplegic migraine can be difficult to distinguish from stroke — seek immediate medical evaluation for any new weakness. 📌 KEY TAKEAWAY Hemiplegic migraine is a rare but serious subtype — motor weakness is the hallmark. Always seek immediate medical evaluation for new weakness, as it can mimic a stroke. Genetic testing and specialist referral are recommended for suspected cases. 🔄 STROKE vs HEMIPLEGIC MIGRAINE — KEY DIFFERENCES 🚨 STROKE 💪 HEMIPLEGIC MIGRAINE • Sudden onset, maximal at start • Weakness is permanent without treatment • Gradual onset, spreads over minutes • Weakness resolves over hours to days Clinical guide — consult a neurologist or headache specialist for diagnosis and management
🤫 SILENT MIGRAINE (AURA WITHOUT HEADACHE) Also called "acephalgic migraine" — aura occurs without the headache phase 📖 DEFINITION What is Silent Migraine? Migraine with aura but no headache Also called acephalgic migraine Aura occurs without the pain phase More common in middle-aged adults Often underdiagnosed or misdiagnosed May still cause significant disability Can occur at any age but peaks in 40s–50s ⚠️ SYMPTOMS (AURA TYPES) Common Aura Symptoms: Visual: zigzags, flashes, blind spots Sensory: numbness, tingling, pins & needles Speech: difficulty finding words, slurring Motor: weakness (rare, hemiplegic) Brainstem: vertigo, tinnitus, double vision Aura lasts 5–60 minutes typically May have prodrome / postdrome without pain 📋 DIAGNOSTIC APPROACH Key Diagnostic Points: Aura symptoms fulfilling ICHD-3 criteria No headache during or after aura History of migraine with aura in the past Symptoms are reversible and gradual Exclude stroke, TIA, seizure, and other causes Imaging if first episode or atypical features Diagnosis is clinical — no confirmatory test Keep a symptom diary to identify patterns 🔍 DIFFERENTIAL DIAGNOSIS Must Rule Out: TIA / stroke • Sudden onset, negative symptoms, vascular risk Seizure (focal with aura) • Brief, stereotyped, impaired consciousness Transient global amnesia • Sudden memory loss, no focal deficits Retinal detachment / vitreous hemorrhage • Monocular visual symptoms Optic neuritis / eye disease • Pain with eye movement, visual loss 💊 TREATMENT Acute Treatment: Usually not needed — no headache NSAIDs / acetaminophen if mild pain Triptans may help if headache develops (discuss with your doctor first) Preventive Treatment: Consider if aura is frequent / disabling Beta-blockers (propranolol) Calcium channel blockers Anticonvulsants (topiramate, valproate) 🚨 WHEN TO SEEK EMERGENCY CARE Call emergency services if: Sudden, severe "thunderclap" headache Weakness / numbness lasting >60 minutes Difficulty speaking or understanding Loss of consciousness / confusion First-ever aura episode Symptoms mimicking stroke New visual loss in one eye ⚠️ Silent migraine is a diagnosis of exclusion — always rule out stroke, TIA, seizure, and other serious causes before confirming this diagnosis. 📌 KEY TAKEAWAY Silent migraine is real — aura without headache can still cause significant disability. It is often underdiagnosed because patients do not associate symptoms with migraine. Always rule out serious causes — seek urgent evaluation for new or prolonged symptoms. 🔄 SILENT MIGRAINE vs TIA (Stroke Warning) 🤫 SILENT MIGRAINE 🚨 TIA (Stroke Warning) • Gradual onset, spreads over 5+ minutes • Positive phenomena (flashing, tingling) • Sudden onset, maximal immediately • Negative phenomena (loss of function)
👁️ RETINAL (OCULAR) MIGRAINE A rare migraine variant causing temporary vision loss in one eye — requires urgent evaluation 📖 DEFINITION What is Retinal Migraine? Rare subtype of migraine with aura Repeated attacks of monocular visual loss Vision loss is temporary and reversible One eye only (monocular) — key feature Headache may follow or be absent Very rare — must exclude serious causes ⚠️ SYMPTOMS Visual Symptoms (One Eye): Blind spots (scotoma) Temporary blindness Flashing lights / scintillations Visual blurring / graying out Symptoms resolve within 60 minutes Headache may follow visual loss 📋 DIAGNOSTIC CRITERIA (ICHD-3) Retinal Migraine Criteria: ≥2 attacks fulfilling criteria B and C Aura with monocular visual symptoms • Scotoma, blindness, or scintillations • Confirmed by examination or patient drawing At least 2 of the following: • Spreads gradually over ≥5 minutes • Lasts 5–60 minutes • Accompanied or followed by headache Not better accounted for by another cause 🔍 DIFFERENTIAL DIAGNOSIS Must Rule Out (Urgent): Amaurosis fugax (TIA of the eye) • Carotid artery disease, emboli Retinal artery occlusion • Sudden, painless vision loss — emergency Retinal vein occlusion • Blood and thunder fundus Optic neuritis • Pain with eye movement, MS association Vitreous hemorrhage / retinal detachment 💊 TREATMENT Acute Treatment: NSAIDs / acetaminophen Antiemetics if nausea present Triptans — use with caution (vasoconstrictive — may worsen retinal ischemia) Preventive Treatment: Beta-blockers (propranolol) Calcium channel blockers Anticonvulsants (topiramate) Avoid triggers + lifestyle modification 🚨 WHEN TO SEEK EMERGENCY CARE Call emergency services if: Sudden, painless vision loss Vision loss lasting >60 minutes Vision loss with weakness / numbness Difficulty speaking or understanding Severe headache with vision changes New floaters / flashes / curtain across vision ⚠️ Retinal migraine is a diagnosis of exclusion always rule out serious vascular and ocular causes before confirming this diagnosis. 📌 KEY TAKEAWAY Retinal migraine is rare and affects only one eye — vision loss is temporary but alarming. It is a diagnosis of exclusion — always rule out serious vascular and ocular causes first. Seek urgent medical evaluation for any sudden vision loss, even if it resolves. 🔄 RETINAL MIGRAINE vs TIA (Amaurosis Fugax) 👁️ RETINAL MIGRAINE 🚨 TIA (Amaurosis Fugax) • Gradual onset, spreads over minutes • Positive phenomena (flashing lights) • Headache may follow, young patients • Sudden onset, maximal immediately • Negative phenomena (curtain, blackout) • No headache, older patients with vascular risk
🔄 VESTIBULAR MIGRAINE (VERTIGO-PREDOMINANT) A common cause of recurrent vertigo — often underdiagnosed and undertreated 📖 DEFINITION What is Vestibular Migraine? Recurrent episodes of vertigo / dizziness Associated with migraine features Headache may be absent in up to 50% One of the most common causes of spontaneous vertigo Often misdiagnosed as Meniere's disease ⚠️ SYMPTOMS Vestibular Symptoms: Spontaneous vertigo (spinning) Positional vertigo (head movement) Lightheadedness / disequilibrium Motion sensitivity / intolerance Nausea / vomiting during episodes Episodes last minutes to hours 📋 DIAGNOSTIC CRITERIA (ICHD-3) Definite Vestibular Migraine: ≥5 episodes of vestibular symptoms (moderate to severe, lasting 5 min–72 hrs) Current or past history of migraine At least 50% of episodes have: • Migraine features (headache, photo/phonophobia) • Or vestibular symptoms triggered by migraine triggers Not better accounted for by another diagnosis Probable: similar but fewer criteria met 🎯 COMMON TRIGGERS Vestibular-Specific Triggers: Visual motion (crowds, traffic, screens) Head movement / positional changes Busy patterns / stripes / high contrast Stress / anxiety Sleep deprivation or irregular sleep Certain foods (caffeine, alcohol, MSG) Weather / barometric pressure changes 💊 TREATMENT Acute Treatment: Vestibular suppressants (short-term) Antiemetics (nausea / vomiting) Triptans (if migraine headache present) Preventive Treatment: Beta-blockers (propranolol) Calcium channel blockers (flunarizine) Anticonvulsants (topiramate) Vestibular rehabilitation therapy (VRT) 🔍 DIFFERENTIAL DIAGNOSIS Conditions to Rule Out: Meniere's disease • Hearing loss, tinnitus, aural fullness BPPV (Benign Paroxysmal Positional Vertigo) • Brief positional vertigo, positive Dix-Hallpike Vestibular neuritis • Acute, prolonged vertigo, no hearing loss Central causes (stroke, TIA, MS) • Neurological signs, sudden onset 📌 KEY TAKEAWAY Vestibular migraine is one of the most common causes of recurrent vertigo. Headache may be absent in up to 50% of patients — do not rule out migraine just because there is no pain. Treatment focuses on migraine prevention, not just vestibular suppression. 🔄 VESTIBULAR MIGRAINE vs MENIERE'S DISEASE 🔄 VESTIBULAR MIGRAINE 👂 MENIERE'S DISEASE • No hearing loss (usually) • Headache / photo-phonophobia may be present • Fluctuating hearing loss, tinnitus • Aural fullness, progressive hearing loss
Menstrual & Hormonal Migraine

Diagonosis

Clinical Differential Guide

Diagnosis & Differential Analysis of Migraine

Distinguish primary headache disorders, evaluate red-flag symptoms, and implement evidence-based diagnostic protocols.

1. Primary Headache Differential Matrix

Clinical Feature Migraine Tension-Type Sinus Headache Cluster Headache
Location Unilateral (60%) or bilateral Bilateral ("band-like") Facial/periorbital sinus tracts Strictly orbital, supraorbital, or temporal
Pain Quality Pulsating / throbbing Dull, tightening, pressing Dull, aching pressure Excruciating, sharp, "piercing"
Duration 4 to 72 hours 30 minutes to 7 days Days to weeks (resolves with infection) 15 to 180 minutes
Associated Features Nausea, photophobia, phonophobia, aura No nausea; mild photophobia OR phonophobia Purulent nasal discharge, fever, anosmia Ipsilateral lacrimation, miosis, ptosis, restlessness

2. Diagnostic Triage & Red-Flag Flowchart

PATIENT PRESENTING WITH HEADACHE
STEP 1: Screening for SNOOP4 Red Flags & Stroke Mimics
• Systemic symptoms (fever, weight loss, cancer history)
• Neurological deficits (unilateral motor weakness, dysarthria, sudden numbness)
• Onset (sudden "thunderclap" peak < 1 minute)
• Older age of onset (> 50 years)
• Pattern change or progressive worsening
If RED FLAGS Present:
Immediate Emergency Evaluation & Neuroimaging (MRI / CT Angiography) to rule out Stroke, TIA, Intracranial Hemorrhage, or Mass.
If RED FLAGS Absent:
Proceed to Step 2: ICHD-3 Criteria Verification for Primary Headache Disorders.
STEP 2: ICHD-3 Primary Diagnosis Criteria
• $\ge 5$ lifetime attacks lasting 4–72 hours
• Pain meeting $\ge 2$ features (unilateral, pulsating, moderate/severe, aggravated by routine activity)
• Accompanied by $\ge 1$ symptom (nausea/vomiting OR photophobia + phonophobia)

3. Red-Flag Symptoms & Stroke Mimics

Certain headache presentations mimic acute ischemic strokes or transient ischemic attacks (TIAs), particularly hemiplegic migraine. Immediate emergency care is required if any of the following are observed:

  • Sudden, severe motor weakness or paralysis on one side of the face or body
  • Difficulty speaking, slurred speech (dysarthria), or inability to understand language (aphasia)
  • Sudden "thunderclap" onset reaching maximum pain intensity within seconds
  • Headache accompanied by high fever, stiff neck, confusion, or loss of consciousness

Scientific References & Evidence Base

A study by Ashina et al., 2021 stated that 'migraine is a complex neurovascular disorder driven by central sensitization, where chronic transformation involves alteration in trigeminovascular processing.'

A study by Headache Classification Committee of the International Headache Society (IHS), 2018 stated that 'diagnosis of migraine without aura requires at least five attacks lasting 4–72 hours fulfilling specific pain and symptom features, whereas migraine with aura requires at least two attacks with reversible focal neurological symptoms.'

A study by Dodick, 2003 stated that 'the presence of red flag features including systemic symptoms, neurological deficits, sudden onset, older age at onset, or pattern change necessitates neuroimaging to rule out underlying structural pathology.'

  1. Ashina, M., Terwindt, G.M., Steiner, T.J., Lee, M.J., Porreca, F., Tassorelli, C., Olesen, J., Dodick, D.W. and Jensen, R.H., 2021. Migraine: disease physiological mechanisms and new pharmacological targets. Nature Reviews Neurology, 17(8), pp.511–521. Available at: https://doi.org/10.1038/s41582-021-00509-5.
  2. Dodick, D.W., 2003. Clinical practice: Chronic daily headache. The Journal of Headache and Pain, 4(1), pp.S16–S24. Available at: https://doi.org/10.1186/1129-2377-4-S1-S16.
  3. Headache Classification Committee of the International Headache Society (IHS), 2018. The International Classification of Headache Disorders, 3rd edition (ICHD-3). Cephalalgia, 38(1), pp.1–211. Available at: https://doi.org/10.1177/0333102417738202.
Migraine Diagnosis — Visual Clinical Guide

🧠 Migraine Diagnosis Visual Clinical Guide

How to distinguish migraine from tension-type, sinus, and cluster headaches with red-flag warning signs.

1 Migraine vs. Tension-Type Headache

The most common diagnostic challenge in clinical practice

🧠 Migraine

One-sided • Throbbing

😣 Tension-Type

Bilateral • Pressing band
FeatureTension-TypeMigraine
LocationBilateralUnilateral (one side)
QualityPressing / tighteningPulsating / throbbing
IntensityMild–moderateModerate–severe
ActivityNot aggravatedAggravated / avoided
NauseaAbsentCommon
Light/SoundNot sensitivePhotophobia / phonophobia
A study by Ashina et al. (2021) stated that "tension-type headache and migraine are distinct disorders, but they can coexist and overlap, complicating diagnosis."

2 Migraine vs. Sinus Headache

Most "sinus headaches" are actually migraines

👃 True Sinus Headache

Fever • Discolored mucus

🧠 Migraine Mimic

Clear discharge • No fever
FeatureSinus HeadacheMigraine
Nasal dischargeThick, yellow/greenClear, watery
FeverUsually presentAbsent
DurationDays to weeks4–72 hours
TriggersCold / allergyStress, foods, hormones
TreatmentAntibiotics, decongestantsTriptans, NSAIDs, rest
A study by Levine et al. (2006) stated that "the majority of sinus headaches can actually be classified as migraines," emphasizing the need to differentiate before treatment.

3 Migraine vs. Cluster Headache

Cluster headache is a neurological emergency — often called "suicide headache"

🧠 Migraine — Lies Still

🛏️ Prefers lying down

🔴 Cluster — Paces

🏃 Pacing • Restless
FeatureMigraineCluster Headache
Sex ratioFemale > Male (3:1)Male > Female (3–4:1)
Pain qualityThrobbingExcruciating, piercing
Duration4–72 hours15–180 minutes
FrequencyEpisodic/chronic1–8/day in clusters
Autonomic signsMildHallmark: tearing, ptosis
BehaviorLies stillPaces, cannot sit
Acute treatmentTriptans, NSAIDsHigh-flow O₂, sumatriptan
A study by Eigenbrodt et al. (2021) stated that "migraine remains under-diagnosed and under-treated" despite affecting over one billion people worldwide.

4 Diagnosis and Treatment

ICHD-3 clinical criteria and evidence-based management

📋 ICHD-3 Diagnostic Workflow

1. HISTORY ≥5 attacks Headache diary Family history 2. ICHD-3 4–72 hours Unilateral • Pulsating Nausea • Photo/phonophobia 3. EXAM Neuro exam BP • Fundoscopy Rule out secondary 4. TREAT Triptan + NSAID Anti-emetic Preventive if needed
TreatmentRecommendation
First-line acuteOral triptan + NSAID (or paracetamol)
MonotherapyTriptan, NSAID, aspirin 900mg, or paracetamol
Anti-emeticConsider even without nausea
AvoidErgotamines, opioids
PreventivePropranolol, topiramate, amitriptyline, CGRP inhibitors
A study by Robblee et al. (2025) stated that "intravenous prochlorperazine and greater occipital nerve blocks now carry a level A 'must offer' designation" for emergency department migraine treatment.

5 When to See a Doctor — Red-Flag Symptoms

Stroke mimics and secondary headache warning signs

🚨 Seek Urgent Medical Care If You Have:

  • Thunderclap headache — "worst headache of my life," reaches maximum in seconds
  • Fever + stiff neck — possible meningitis
  • Focal neurological deficits — weakness, numbness, speech difficulty, confusion
  • Sudden vision loss — painless, monocular, curtain across vision
  • New headache after age 50 — lower threshold for secondary causes
  • Progressive worsening — over weeks, not episodic

Migraine Aura vs. TIA/Stroke

FeatureMigraine AuraTIA / Stroke
OnsetGradual, spreads over ≥5 minSudden, maximal immediately
PhenomenaPositive (flashing, tingling)Negative (loss of function)
Duration5–60 minutesVariable, often >60 min
HeadacheOften followsUsually absent
AgeYounger (teens–40s)Older (vascular risk factors)
A study by Scutelnic et al. (2024) stated that "the optimal combination of clinical markers to reliably distinguish TIA from migraine aura remains to be found."
📌 Key Takeaway: Migraine is a clinical diagnosis — no blood test or imaging confirms it. Accurate differentiation from tension-type, sinus, and cluster headaches guides treatment. Always rule out red flags before confirming a primary headache disorder.
Educational guide — consult a neurologist or headache specialist for diagnosis and management.
ICHD-3 — International Classification of Headache Disorders, 3rd edition.

Treatment: Acute/Abortive

Clinical Pharmacology Module

Acute & Abortive Migraine Treatment Options

Comprehensive evidence-based management of acute attacks, pharmacotherapy profiles, and emergency protocols.

1. Therapeutic Mechanisms in Acute Migraine

Abortive drugs target trigeminovascular signaling, CGRP release, and central sensitization through diverse receptor pathways.

💊
5-HT1B/1D Agonists (Triptans)

Direct dural vasoconstriction & presynaptic CGRP inhibition

🧬
CGRP Antagonists (Gepants)

Block CGRP binding without causing vascular constriction

🧠
5-HT1F Agonists (Ditans)

Selective central trigeminal inhibition without vasoconstriction

🧪
COX Inhibitors & Anti-Emetics

Prostaglandin blockade & central dopamine D2 antagonism

2. Triptan Profile Comparison (5-HT1B/1D Agonists)

Drug Name Onset of Action Half-Life (t½) Primary Features / Clinical Niche
Sumatriptan 10–15 min (SC), 30 min (Nasal), 60 min (Oral) 2 hours Gold standard benchmark; multiple delivery routes for rapid relief
Rizatriptan 30 minutes 2–3 hours Rapid onset oral wafer/ODT; dose-reduce to 5mg with propranolol
Eletriptan 30–45 minutes 4 hours High lipophilicity and bioavailability; effective for recurrence
Zolmitriptan 15 min (Nasal), 45 min (Oral) 3 hours Available in nasal spray and oral disintegrating tablet (ODT)
Almotriptan 30–45 minutes 3–4 hours High oral bioavailability; excellent tolerability profile
Naratriptan 1–2 hours 6 hours Slower onset; lower adverse effect rate and recurrence rate
Frovatriptan 2 hours 26 hours Longest half-life; preferred for short-term menstrual prophylaxis

3. NSAIDs, OTC Options & Novel Target Classes

NSAIDs & Combination Analgesics

First-line for mild-to-moderate attacks. Ibuprofen, naproxen sodium, and diclofenac potassium inhibit prostaglandin synthesis. Aspirin-acetaminophen-caffeine combinations enhance absorption and efficacy.

Gepants (Ubrogepant, Rimegepant)

Small-molecule CGRP receptor antagonists (Ubrelvy, Nurtec ODT). Effective for patients with cardiovascular contraindications to triptans due to lack of vasoconstrictive effects.

Lasmiditan (Reyvow - Ditan Class)

Selective 5-HT1F receptor agonist without vasoconstrictive activity. Requires an 8-hour driving restriction post-dose due to central nervous system depression and sedation.

Anti-Nausea & Prokinetic Agents

Metoclopramide and prochlorperazine relieve gastroparesis and nausea while providing synergistic central analgesic effects. Ondansetron targets 5-HT3 receptors for pure emetic control.

4. Status Migrainosus Emergency Protocol

Continuous, debilitating migraine attacks lasting longer than 72 hours require intensive intravenous rescue therapy.

Step 1 — Hydration: IV normal saline 1L if vomiting, check serum electrolytes.
Step 2 — IV Antiemetic: Metoclopramide 10mg IV or prochlorperazine 12.5mg IV.
Step 3 — IV NSAID / Steroid: Ketorolac 30mg IV or dexamethasone 10mg IV (dexamethasone reduces 24–72h recurrence risk by 25%).
Step 4 — DHE or Second-Line: Dihydroergotamine 0.5–1mg IV with antiemetic pretreatment, valproate 500–1000mg IV, or magnesium sulfate 1–2g IV.
Step 5 — Inpatient Rescue: If refractory post-72h, urgent neurology referral for continuous DHE or lidocaine infusion. Never use opioids as first-line therapy.
🚨
Red Flags to Exclude: Thunderclap onset, fever, neck stiffness, focal neurological deficits, or papilledema. Immediate neuroimaging required to rule out subarachnoid hemorrhage, meningitis, or cerebral infarction.

Validated Evidence & References

A study by Ailani et al., 2021 stated that 'the integration of CGRP-targeting small molecules provides effective acute migraine abortive options for patients who have inadequate responses or cardiovascular contraindications to triptans.'

A study by Sacco et al., 2024 stated that 'adherence to European Academy of Neurology guidelines standardizes early acute intervention and prevents transition to chronic daily headache.'

A study by Diener et al., 2019 stated that 'overuse of acute migraine medications for 10 to 15 days per month depending on drug class promotes secondary central sensitization and headache chronification.'

  1. Ailani, J., Burch, R.C., Robbins, M.S. and Board of Directors of the American Headache Society, 2021. The American Headache Society Consensus Statement on Integrating New Migraine Treatments Into Clinical Practice. Headache, 61(7), pp.1021–1039. Available at: https://doi.org/10.1177/03331024211018675.
  2. Diener, H.C., Holle, D., Solbach, K. and Gaul, C., 2019. Medication-overuse headache: risk factors, pathophysiology and management. Nature Reviews Neurology, 15(11), pp.620–634. Available at: https://doi.org/10.1038/s41582-019-0217-5.
  3. Sacco, S., Amin, F.M., Ashina, M., Aranyi, Z., Ayata, C., De la Torre, E.R., Gil-Gouveia, R., Gantenbein, A.R., Katsarava, Z., Linde, M. and Martelletti, P., 2024. European Academy of Neurology guideline on the management of migraine in adults. European Journal of Neurology, 31(7), p.e16307. Available at: https://doi.org/10.1111/ene.16307.
Was this article helpful?
1 vote · Your choice helps us improve